Final Word Determining how much bacteriostatic water to add to peptides requires careful consideration of the peptides quantity, desired dosage, and administration method
Some people report weight changes with lower doses, but results vary
GLP-1 Receptor Agonists [review]
p=0.0099) and a significant increase in the percentage of nausea-free days a week 4 (28.8% versus 15%, respectively

Results: Additional findings: 14.1% (9 mg) and 12.0% (12 mg) achieved complete freedom from knee pain Significant reductions in cardiovascular risk markers 14.0 mmHg reduction in systolic blood pressure at highest dose Reductions in non-HDL cholesterol, triglycerides, and inflammatory markers Liver fat reduction (MASLD substudy) A separate analysis looked at retatrutide's effect on metabolic dysfunction-associated steatotic liver disease (formerly NAFLD): Liver fat reduction at 24 weeks: Achievement of normal liver fat ( 20%) Patients with multiple metabolic conditions Who should avoid it Contraindications based on trial exclusions: Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 Pregnancy or planning pregnancy Severe kidney disease History of pancreatitis Active gallbladder disease For women-specific considerations, see our peptides for menopause guide

The FDA has cautioned about "impurities," the use of an untested "salt" form of semaglutide in compounded drugs, and "adverse events," which encompass everything from mild side effects like nausea to life-threatening reactions and even death